Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer
Autor: | S. Chan, Armstrong, A., Raja, F., Schmid, P., Tutt, A., Roux, R., Cleator, S., Turner, N.C., Swift, C., Jenkins, B., Kilburn, L., Coakley, M., Beaney, M., Fox, L., Goddard, K., Garcia-Murillas, I., Proszek, P., Hall, P., Harper-Wynne, C., Hickish, T., Kernaghan, S., Macpherson, I.R., Okines, A.F.C., Palmieri, C., Perry, S., Randle, K., Snowdon, C., Stobart, H., Wardley, A.M., Wheatley, D., Waters, S., Winter, M.C., Hubank, M., Allen, S.D., Bliss, J.M. |
---|---|
Zdroj: | In Annals of Oncology February 2023 34(2):200-211 |
Databáze: | ScienceDirect |
Externí odkaz: |